Page 351 - ATP-P 11th Ed
P. 351

Indications: As a topical optic anesthetic (may aid in ocular exam to relieve blepharo-
        spasm); removal of foreign bodies.
        Dose:
        •  1 or 2 drops – 2–3min before procedure.
        •  See appropriate TMEP
        Contraindications: Not for prolonged use.
        Pregnancy Category C
        Side-effects:
        •  Stinging
        •  Tearing
        •  Swelling
        •  Sensitivity to light
        Adverse reactions:
        •  Conjunctival redness
        •  Transient eye pain
        •  Hypersensitivity reactions
        TMEP use: Corneal Abrasion, Corneal Ulcer, Conjunctivitis Protocol    SECTION 3

              ®
        Toradol  – See Ketorolac
                                   ®
        Tranexamic Acid (TXA) (Cyklokapron )
        Class: Antifibrinolytic agent
        Action: Competitive inhibitor of plasminogen activation → stabilizes clots.
        Indications: (Off label) Combat casualties at high risk for requiring massive blood transfu-
        sion (e.g., presenting with hemorrhagic shock, penetrating torso trauma, multiple major
        amputation, or clinical evidence of severe blood loss).
        Dose: Adult 1g IV/IO for 2 doses
             K9 Dose: 10–15 mg/kg IV
        Contraindications:
        •  Subarachnoid hemorrhage
        •  Active intravascular clotting
        •  Known hypersensitivity
        Pregnancy Category B
        Side-effects:
        •  Cardiovascular – angina pectoris, chest pain, hypotension, myocardial infarction, pos-
          tural hypotension, tachycardia
        •  Digestive – dose-related nausea, vomiting, and diarrhea
        •  Ophthalmologic – blurred vision, conjunctivitis (including conjunctival hyperemia), eye
          pain, color blindness


                                              ATP-P Handbook 11th Edition 341
   346   347   348   349   350   351   352   353   354   355   356